Applications of Artificial Intelligence in Healthcare

Dr. Bagchi is an academic, industry, and clinical-affairs leader in nutraceuticals, functional foods, toxicology, pharmacology, and nutrition science. He holds adjunct faculty appointments at Texas Southern University and Adelphi University, where he contributes to teaching in neurotoxicology and integrative neuroscience, and serves as Director of Innovation and Clinical Affairs at Dr. Herbs LLC. He previously held faculty and senior research leadership roles in pharmaceutical sciences, nutraceuticals, and scientific affairs. Dr. Bagchi has held leadership positions in professional organizations including the International Society of Nutraceuticals and Functional Foods, the American College of Nutrition, and the Institute of Food Technologists’ Nutraceuticals and Functional Foods Division. His work includes extensive peer-reviewed publications, edited books, and patents. He serves in advisory, peer-review, and editorial roles for scientific organizations and journals, with contributions spanning functional foods, nutrition, toxicology, oxidative stress, and biomedical research. Samudra Prosad Banik, Ph.D., received his PhD degree in Life Sciences from Jadavpur University in 2009 after working in the field of Fungal Biotechnology from the CSIR –Indian Institute of Chemical Biology, Kolkata, India. Dr. Banik is currently working as Assistant Professor at the Department of Microbiology, Maulana Azad College, University of Calcutta at Kolkata, India. After completing his Masters in Biophysics and Molecular Biology at the University of Kolkata in 2003, Dr. Banik was awarded a travel grant to work in a short project of genetically engineered rice with increased photosynthetic efficiency at International Rice Research Institute, Philippines. Thereafter he completed his PhD. at IICB where he identified an alternative pathway of vesicles mediated protein secretion in filamentous fungus, and performed biophysical characterization of the glycosylated fungal enzyme assemblies. Upon joining Maulana Azad College, Dr. Banik continued his research on behavior of glycosylated/glycated proteins in higher eukaryotes. In the process, he eventually shifted his attention towards glycated proteins formed during hyperglycemia and its associated consequences chiefly with regards to neuronal disorders. He has been the recipient of three research projects and has published more than 32 research articles in SCOPUS/Web of Science indexed journals along with 15 book chapters published by CRC Press/Wiley/CRC Press. Dr. Banik has edited one book on Biofuels which is scheduled to come out early next year from CRC Press/Taylor and Francis. He is an active reviewer of significant journals including Heliyon, PLOS One and Journal of American Nutrition Association. He is presently the Joint-Convenor of Research Committee at Maulana Azad College. His current research interests include understanding the mechanism of stabilization of proteins by osmolytes as well as structural changes inflicted in proteins due to glycation. Anand Swaroop is a trained scientist turned entrepreneur with a rich background in biochemistry. After spending a decade in various positions in the pharmaceutical sector, he began exploring natural product chemistry. Over the last three decades, Dr. Swaroop has earned diversified global management experience in the Natural Products business. His expertise includes natural product chemistry, research, supply chain management, and strategic planning. His diverse experience in research, quality assurance, product development, manufacturing, and marketing has given him a unique and multidisciplinary perspective on the industry. In 2016, he was selected as a Fellow of the American College of Nutrition. He's also a member of the task force constituted by the Government of India in 2021 to recommend the development of the Nutraceutical Sector in India and worldwide for Ayurvedic products. Currently he's the Founder President of reputable companies, including Cepham Inc., Nutrify Today, and Cepham Life Sciences Inc. Sunny Ohia is a Professor of Pharmacology in the College of Pharmacy and Health Sciences at Texas Southern University. Dr. Ohia has over 38 years of experience in higher education having served as a member of faculty in five universities in Canada and the United States. He holds other academic appointments as adjunct professor of ophthalmology and visual sciences at the University of Nebraska Medical Center, Omaha and as an adjunct professor of integrative biology and pharmacology at the University of Texas Health Sciences Center in Houston. Dr. Ohia is a Fellow of the Nigerian Academy of Science and a Fellow of the Association for Research in Vision and Ophthalmology. He's authored over 250 original papers, book chapters, books, and abstracts and, holds three U.S. and five international Patents for his scientific work.

• Section 1: Introduction to AI and Healthcare1. Introduction to Fundamentals of AI Application in Healthcare2. Bottlenecks in Medical Science: Why do We Need the Interventions of AI3. Fuzzy Rule-based Systems for Disease Diagnosis4. The Potential of Quantum AI in Augmentation of Human HealthSection 2: The Role of AI in Holistic Healthcare and Disease Diagnosis5. State-of-the-Art AI Assisted Disease Detection Tools6. AI in Biomedical Image Processing7. Use of AI Chatbots for Primary Diagnosis at Home8. AI Assisted Imaging Technologies for Disease Diagnosis9. AI for Detection and Arrest of Infectious Diseases10. Understanding Key Algorithms for Construction of AI Assisted Prediction Tools11. Minimizing Vulnerability of AI Programmes from Cyber-attacksSection 3: Use of AI in Organ Transplantation and Precision Surgery12. Predictive AI to Increase Success of Heart Transplantation13. AI Assisted Augmented Reality Overlay in Precision Surgeries14. AI Driven Robotics in Neurosurgery15. AI in Minimally Invasive Surgeries16. AI in Cosmetic SurgerySection 4: Domain Specific Applications in Medical Science through AI Intervention17. Use of AI in Assisted Reproduction18. AI for Management of Cardiovascular Diseases19. AI in Telemedicine: The Evolution of Virtual Ophthalmology20. The Role of Machine Learning in Autoimmune Disease Prediction21. AI in Psychotherapy and Counseling22. AI in Detecting and Mitigation of Neurological Disease23. AI in Remote Monitoring of PatientsSection 5: New Frontiers of AI24. The Evolution of ChatGPT in AI Assisted Biomedical Care25. Role of Generative AI in Drug Designing, Toxicity Assessment and Bio-diversity26. AI-based Predictive Models for Nutraceutical and Functional Food Industry27. AI-enabled Organoids for Clinical Applications28. Medicinal Plant IsolatesSection 6: Conclusion: The Future of AI29. Regulatory, Federal, and Ethical Issues of AI in Biomedical Applications30. Commentary: The Evolution of AI and its Implications for Future Human Generation